INDOUS
Start SIP
Invest Now
Start SIP in INDOUS
Performance
- Low
- ₹123
- High
- ₹126
- 52 Week Low
- ₹105
- 52 Week High
- ₹235
- Open Price₹126
- Previous Close₹126
- Volume26,072
- 50 DMA₹123.65
- 100 DMA₹130.32
- 200 DMA₹147.19
Investment Returns
- Over 1 Month + 4.92%
- Over 3 Month -5.62%
- Over 6 Month -29.96%
- Over 1 Year -44.17%
Smart Investing Starts Here Start SIP with Indo US Bio-Tech for Steady Growth!
Indo US Bio-Tech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 17
- PEG Ratio
- 1.3
- Market Cap Cr
- 253
- P/B Ratio
- 2.9
- Average True Range
- 9.06
- EPS
- 7.4
- Dividend Yield
- 0
- MACD Signal
- 0.51
- RSI
- 54.72
- MFI
- 48.51
Indo US Bio-Tech Financials
Indo US Bio-Tech Technicals
EMA & SMA
Current Price
₹125.90
+
0.3
(0.24%)
- Bearish Moving Average 0
- Bullish Moving Average 0
- 20 Day
- ₹122.56
- 50 Day
- ₹123.65
- 100 Day
- ₹130.32
- 200 Day
- ₹147.19
Resistance and Support
125.05
- R3 138.60
- R2 133.80
- R1 129.85
- S1 121.10
- S2 116.30
- S3 112.35
Indo US Bio-Tech Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-01-21 | Quarterly Results | |
| 2025-11-14 | Quarterly Results | |
| 2025-10-14 | Others | Inter-alia, to consider 1. Re-appointment of M/s. Gautam N Associates as a Statutory Auditors of the Company. 2. Approve Notice of Postal Ballot. 3. Other business matters. per share(2.5%)Interim Dividend |
| 2025-08-12 | Quarterly Results | |
| 2025-05-26 | Audited Results |
Indo US Bio-Tech F&O
About Indo US Bio-Tech
- NSE Symbol
- INDOUS
- BSE Symbol
- 541304
- Managing Director
- Mr. Jagdish Ajudia
- ISIN
- INE250Z01010
Similar Stocks to Indo US Bio-Tech
Indo US Bio-Tech FAQs
Indo US Bio-Tech share price is ₹125 As on 08 February, 2026 | 16:11
The Market Cap of Indo US Bio-Tech is ₹252.5 Cr As on 08 February, 2026 | 16:11
The P/E ratio of Indo US Bio-Tech is 17 As on 08 February, 2026 | 16:11
The PB ratio of Indo US Bio-Tech is 2.9 As on 08 February, 2026 | 16:11
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.